
💯D👀KS💯 | co-founder of 💯club💯 | chemical researcher and managing partner of Elite Research USA | life’s too short to be soft little bitch | #DOWORKSON
United States
Joined December 2025
- Tweets7.9K
- Following1.6K
- Followers5.4K
- Likes11.5K
🔥🔥🔥🔥🐕SALE IS LIVE🐕🔥🔥🔥🔥
15% OFF SITE WIDE… PLUS 10% W YOUR FAVORITE AFFILIATE CODE
15% OFF EXCLUDES PRETOX, UNLEASHED, AND KITCHEN SINK
SALE ENDS SATURDAY AT MIDNIGHT CENTRAL
eliteresearchusa.com
New drop!
We decided to put every fucking peptide in one 3 mL vial. Never been done before! Available soon!
Pre order goes live later.
THE REAL 💯D👀KS💯 retweeted
UNLEASHD Friday!!!
Let’s see pic of your dogs or cats in the comments!!!
Maple, Moose & Murphy
Literally one of the most underrated compounds.
KPV is typically sold in 250mcg-500mcg capsules and is on the expensive end
In the disease/longevity world KPV is known for a wide range of potent effects and if often used by functional and naturopathic doctors in disease therapy.
From autoimmune to cancer.
I’ve personally seen this change so many lives, it actually changed my life when I was in my own battle.
So I decided that we would not only release the highest doses KPV on the market but we would actually sell it for the price other companies sell 250mcg for, so that everyone that actually needs it can afford it
*research use only not for humans*
Nice breakdown and love to hear personal experience. Thanks @MattDChrist 💪🏻
THE REAL 💯D👀KS💯 retweeted
If yall want to know all the details on the Houston Astros tune in to our podcast
youtube.com/@crawfordchron?s…
You don’t know about Emodin?
Emodin is not a single pathway supplement. It is a complete multi-target anthraquinone that simultaneously blocks cortisol regeneration, antagonizes estrogen drive, raises mitochondrial ATP while cutting oxidative damage, and hits anticancer and anti-inflammatory programs most molecules never touch in the same pass.
Before enzyme transcription even enters the picture, emodin selectively shuts down tissue cortisol reactivation, displaces estrogen at the receptor, clears nitric oxide brakes on respiration, and recruits HER-2, HIF-1α, VEGF, MMP, and fibrosis pathways inside one structure.
1. Emodin Starts Upstream: Cortisol Synthesis Blockade and Dual 11β-HSD Control
Emodin's primary stress-hormone target is tissue cortisol regeneration through 11β-hydroxysteroid dehydrogenase type 1, the enzyme that converts inactive cortisone back into active cortisol inside liver and fat.
Selective Nanomolar 11β-HSD1 Inhibition:
Emodin is a potent and selective 11β-HSD1 inhibitor with an IC50 of 186 nM against human 11β-HSD1 (and 86 nM against the mouse enzyme). A single oral dose significantly suppressed 11β-HSD1 activity in liver and fat, reversed prednisone-driven insulin resistance, and improved metabolic readouts including insulin sensitivity, lipid handling, and hepatic gluconeogenic enzymes.
Dual Enzyme Control and Estrogen Antagonism:
Emodin goes further by downregulating 11β-HSD1 expression while raising activity of 11β-HSD2, the enzyme that deactivates cortisol, locking tissue cortisol from both directions at once. It is also a potent estrogen receptor antagonist that displaces estrogen at ER, including ER-α–linked suppression of breast cancer cell proliferation, with inhibitory effects discussed across other estrogen-sensitive cancers including prostate. Relative cortisol excess is a common reason sleep quality collapses after mid life, and reports describe deeper sleep, settled heartbeat, and a relaxed body once that stress tone drops. Cortisol block plus estrogen antagonism is the hormonal background most single-target agents never deliver together.
2. Gut Motility, Mitochondrial Energy, and Anti-Inflammatory Cover
Emodin does not stop at hormone enzymes. It simultaneously supports bowel transit, elevates cellular energy, and calms inflammatory tone at the tissue level.
Colon Motility and Local Inflammation:
Emodin reaching the colon supports bowel movement rhythm, reduces intestinal water over-absorption, and delivers local anti-inflammatory cover exactly where inflamed gut walls impair contractile tone. Digestion reports include smoother elimination, reduced bloating, and visibly improved gut comfort alongside systemic stress-hormone support.
Mitochondrial ATP and Cleaner Respiration:
Emodin increases mitochondrial oxygen consumption and ATP synthesis while decreasing oxidative damage, supports electron transport and NADH recycling back to NAD, and inhibits nitric oxide formation and iNOS so cytochrome oxidase is no longer choked by NO. COX and LOX inhibition add anti-inflammatory metabolic cover on top of the energy lift. Reports of warmer temperature, clearer vision, and higher mood track with that metabolic push.
Endotoxin and Barrier Tone:
Emodin ranks among OTC TLR4 blockers that blunt endotoxin-driven inflammation, reduces vascular leakage, and pairs systemic cortisol control with lower inflammatory drive. Energy up, stress chemistry down: that is the quinone signature.
3. The Anticancer Toolkit That Puts Emodin in a Class of Its Own
Where most anti-inflammatory or cortisol agents stop, emodin recruits HER-2, hypoxia, angiogenesis, invasion, and antifibrotic repair pathways across the same molecule.
HER-2 / Neu Tyrosine Kinase Suppression and Differentiation:
Emodin suppresses HER-2/neu tyrosine kinase autophosphorylation and transphosphorylation, preferentially inhibits growth of HER-2–overexpressing cells, and induces differentiation toward a more orderly, less invasive phenotype.
Hypoxia, Angiogenesis, and Metastatic Invasion:
Under hypoxic inflammatory stress, emodin attenuates COX-2, VEGF, HIF-1α, MMP-1, and MMP-13 at the mRNA level, cutting the hypoxia survival switch, vessel recruitment, and collagenase-driven invasion program in one stroke. Related work links emodin and aloe-emodin to ER-α inhibition in breast cancer models and lower HIF-1α with attenuated cachexia readouts in pancreatic cancer research.
Fatty Acid Synthase, Angiogenesis, and Invasiveness:
Emodin inhibits angiogenesis and invasiveness, blocks fatty acid synthase, and promotes cellular differentiation, collapsing membrane-building and blood-supply pathways aggressive tumors lean on.
Antifibrotic, Antimicrobial, and Systemic Resilience:
Anti-fibrotic studies report reversed fibrosis of heart and liver, with emodin framed as heart protective and as a serotonin antagonist with heart-failure relevance. Broader coverage spans antiviral, antibacterial, and antifungal activity, plus antioxidant, memory-enhancing, and anxiolytic support. One anthraquinone, many disease fronts.
Emodin operates as a complete multi-receptor, multi-enzyme neurometabolic and anticancer anthraquinone by uniting nanomolar 11β-HSD1 cortisol blockade, dual cortisol enzyme control, estrogen antagonism, mitochondrial ATP elevation with lower oxidative damage, nitric oxide and TLR4 cover, gut motility plus colon anti-inflammatory action, HER-2 suppression, HIF-1α / VEGF / MMP attenuation, and antifibrotic systemic repair inside a single molecule.
Big props to my man @AntiDoc on this one… he said bruh please carry it.
Emodin is not a single pathway supplement. It is a complete multi-target anthraquinone that simultaneously blocks cortisol regeneration, antagonizes estrogen drive, raises mitochondrial ATP while cutting oxidative damage, and hits anticancer and anti-inflammatory programs most molecules never touch in the same pass.
Before enzyme transcription even enters the picture, emodin selectively shuts down tissue cortisol reactivation, displaces estrogen at the receptor, clears nitric oxide brakes on respiration, and recruits HER-2, HIF-1α, VEGF, MMP, and fibrosis pathways inside one structure.
1. Emodin Starts Upstream: Cortisol Synthesis Blockade and Dual 11β-HSD Control
Emodin's primary stress-hormone target is tissue cortisol regeneration through 11β-hydroxysteroid dehydrogenase type 1, the enzyme that converts inactive cortisone back into active cortisol inside liver and fat.
Selective Nanomolar 11β-HSD1 Inhibition:
Emodin is a potent and selective 11β-HSD1 inhibitor with an IC50 of 186 nM against human 11β-HSD1 (and 86 nM against the mouse enzyme). A single oral dose significantly suppressed 11β-HSD1 activity in liver and fat, reversed prednisone-driven insulin resistance, and improved metabolic readouts including insulin sensitivity, lipid handling, and hepatic gluconeogenic enzymes.
Dual Enzyme Control and Estrogen Antagonism:
Emodin goes further by downregulating 11β-HSD1 expression while raising activity of 11β-HSD2, the enzyme that deactivates cortisol, locking tissue cortisol from both directions at once. It is also a potent estrogen receptor antagonist that displaces estrogen at ER, including ER-α–linked suppression of breast cancer cell proliferation, with inhibitory effects discussed across other estrogen-sensitive cancers including prostate. Relative cortisol excess is a common reason sleep quality collapses after mid life, and reports describe deeper sleep, settled heartbeat, and a relaxed body once that stress tone drops. Cortisol block plus estrogen antagonism is the hormonal background most single-target agents never deliver together.
2. Gut Motility, Mitochondrial Energy, and Anti-Inflammatory Cover
Emodin does not stop at hormone enzymes. It simultaneously supports bowel transit, elevates cellular energy, and calms inflammatory tone at the tissue level.
Colon Motility and Local Inflammation:
Emodin reaching the colon supports bowel movement rhythm, reduces intestinal water over-absorption, and delivers local anti-inflammatory cover exactly where inflamed gut walls impair contractile tone. Digestion reports include smoother elimination, reduced bloating, and visibly improved gut comfort alongside systemic stress-hormone support.
Mitochondrial ATP and Cleaner Respiration:
Emodin increases mitochondrial oxygen consumption and ATP synthesis while decreasing oxidative damage, supports electron transport and NADH recycling back to NAD, and inhibits nitric oxide formation and iNOS so cytochrome oxidase is no longer choked by NO. COX and LOX inhibition add anti-inflammatory metabolic cover on top of the energy lift. Reports of warmer temperature, clearer vision, and higher mood track with that metabolic push.
Endotoxin and Barrier Tone:
Emodin ranks among OTC TLR4 blockers that blunt endotoxin-driven inflammation, reduces vascular leakage, and pairs systemic cortisol control with lower inflammatory drive. Energy up, stress chemistry down: that is the quinone signature.
3. The Anticancer Toolkit That Puts Emodin in a Class of Its Own
Where most anti-inflammatory or cortisol agents stop, emodin recruits HER-2, hypoxia, angiogenesis, invasion, and antifibrotic repair pathways across the same molecule.
HER-2 / Neu Tyrosine Kinase Suppression and Differentiation:
Emodin suppresses HER-2/neu tyrosine kinase autophosphorylation and transphosphorylation, preferentially inhibits growth of HER-2–overexpressing cells, and induces differentiation toward a more orderly, less invasive phenotype.
Hypoxia, Angiogenesis, and Metastatic Invasion:
Under hypoxic inflammatory stress, emodin attenuates COX-2, VEGF, HIF-1α, MMP-1, and MMP-13 at the mRNA level, cutting the hypoxia survival switch, vessel recruitment, and collagenase-driven invasion program in one stroke. Related work links emodin and aloe-emodin to ER-α inhibition in breast cancer models and lower HIF-1α with attenuated cachexia readouts in pancreatic cancer research.
Fatty Acid Synthase, Angiogenesis, and Invasiveness:
Emodin inhibits angiogenesis and invasiveness, blocks fatty acid synthase, and promotes cellular differentiation, collapsing membrane-building and blood-supply pathways aggressive tumors lean on.
Antifibrotic, Antimicrobial, and Systemic Resilience:
Anti-fibrotic studies report reversed fibrosis of heart and liver, with emodin framed as heart protective and as a serotonin antagonist with heart-failure relevance. Broader coverage spans antiviral, antibacterial, and antifungal activity, plus antioxidant, memory-enhancing, and anxiolytic support. One anthraquinone, many disease fronts.
Emodin operates as a complete multi-receptor, multi-enzyme neurometabolic and anticancer anthraquinone by uniting nanomolar 11β-HSD1 cortisol blockade, dual cortisol enzyme control, estrogen antagonism, mitochondrial ATP elevation with lower oxidative damage, nitric oxide and TLR4 cover, gut motility plus colon anti-inflammatory action, HER-2 suppression, HIF-1α / VEGF / MMP attenuation, and antifibrotic systemic repair inside a single molecule.
THE REAL 💯D👀KS💯 retweeted
Hell yeah brother! I got an older little buddy this will be just perfect for as he ages. Puptides here we go!
THE REAL 💯D👀KS💯 retweeted
If you know me, you know I’m a huge dog lover
I am so pumped for this product & to be able to share it with all of you & your pets
Drop coming soon
🐶 🐱
🔥🔥🔥NEW RESEARCH COMPOUNDS🔥🔥🔥
Available NOW at eliteresearchusa.com
👉🏻TAK-653
👉🏻ALOE EMODIN
Fresh goat this time around. Couple spots left. It’ll be like a hibachi restaurant and I’ll throw rice in your mouth… except it will actually be fresh goat.
We’re coming down to the wire and we have 2 tickets left to Friday’s Bro Science Supper
Check out how legit the last one was with @AbudBakri
And come check Elite Research Co-Founder @trinity2pointO along with @AJA_Cortes & myself just north of ATX
DM me for details
Freshman year in college… played ball for a small college in Abilene, TX. One night we drove out to Anson and that experience literally made me a believer in paranormal. There’s no other explanation for what I witnessed.
Just passed Anson and it reminded me of the only dude I know who's ever gone chasing the lights. @trinity2pointO
The shirt you have on is fitting… it’s what you’ve been doing and will continue to do, Paul. You got this AND you have a family here supporting your effort to overcome it as well. Thank you for the update.





























